- Home
- DMF vs FENC Comparison
DMF vs FENC Comparison
Compare DMF & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DMF
- FENC
- Stock Information
- Founded
- DMF 1988
- FENC 1996
- Country
- DMF United States
- FENC United States
- Employees
- DMF N/A
- FENC N/A
- Industry
- DMF Finance/Investors Services
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DMF Finance
- FENC Health Care
- Exchange
- DMF Nasdaq
- FENC Nasdaq
- Market Cap
- DMF 152.2M
- FENC 156.9M
- IPO Year
- DMF N/A
- FENC 2001
- Fundamental
- Price
- DMF $7.26
- FENC $5.23
- Analyst Decision
- DMF
- FENC Strong Buy
- Analyst Count
- DMF 0
- FENC 2
- Target Price
- DMF N/A
- FENC $14.00
- AVG Volume (30 Days)
- DMF 60.7K
- FENC 125.4K
- Earning Date
- DMF 01-01-0001
- FENC 05-13-2025
- Dividend Yield
- DMF 2.66%
- FENC N/A
- EPS Growth
- DMF N/A
- FENC N/A
- EPS
- DMF 0.15
- FENC N/A
- Revenue
- DMF N/A
- FENC $47,538,000.00
- Revenue This Year
- DMF N/A
- FENC $2.68
- Revenue Next Year
- DMF N/A
- FENC $71.63
- P/E Ratio
- DMF $45.13
- FENC N/A
- Revenue Growth
- DMF N/A
- FENC 123.69
- 52 Week Low
- DMF $5.37
- FENC $3.96
- 52 Week High
- DMF $6.79
- FENC $11.15
- Technical
- Relative Strength Index (RSI)
- DMF 58.25
- FENC 33.10
- Support Level
- DMF $7.13
- FENC $5.47
- Resistance Level
- DMF $7.29
- FENC $6.90
- Average True Range (ATR)
- DMF 0.06
- FENC 0.33
- MACD
- DMF -0.00
- FENC -0.12
- Stochastic Oscillator
- DMF 76.00
- FENC 0.00
About DMF BNY Mellon Municipal Income Inc.
BNY Mellon Municipal Income, Inc. is a non-diversified closed-end management investment company. Its investment objective is to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital. The fund invests in municipal obligations that are rated investment grade and have maturities of less than one year. The company targets to invest in the sector such as education, pre-refunded muni, utility, transportation, healthcare, special tax, state/territory general obligations, industry revenue, and pollution control.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.